Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Assessment of Maintenance Rituximab after First-Line Bendamustine-Rituximab in Patients with Follicular Lymphoma: An Analysis from the BRIGHT Trial

Brad S Kahl, MD, John M. Burke, MD, Richard van der Jagt, MD FRCPC, Julie Chang, MD, Peter Wood, Tim Hawkins, FRACP, FRCPA, David MacDonald, Judith Trotman, MBChB, FRACP, FRCPA, David Simpson, MBChB, Kathryn S. Kolibaba, MD, Samar Issa, FRACP, Doreen Hallman, Ling Chen, Ian W. Flinn, MD PhD

Blood (2017) 130 (Supplement 1): 484.

https://doi.org/10.1182/blood.V130.Suppl_1.484.484

Published: 2017

Journal Articles

Open-Label Study of Bendamustine Hydrochloride in Chinese Patients with Indolent Non-Hodgkin Lymphoma (NHL) Refractory to Rituximab Treatment

Yuan-Kai Shi, Xiao Nan Hong, Hui Qiang Huang, Wei Xu, Ling Chen, Udo Mueller

Blood (2016) 128 (22): 5340.

https://doi.org/10.1182/blood.V128.22.5340.5340

Published: 2016

Journal Articles

Down-Regulation of c-Kit Receptor on Hematopoietic Cells By Stem Cell Factor (SCF; c-Kit-ligand): No Impact on Transplantation

Emanuel Necas, MD, PhD, Chia-Ling Chen, Katerina Faltusova, Ko-Tung Chang, PhD

Blood (2014) 124 (21): 5115.

https://doi.org/10.1182/blood.V124.21.5115.5115

Published: 2014

Journal Articles

Modeling de novo leukemogenesis from human cord blood with MN1 and NUP98HOXD13

Suzan Imren, Michael Heuser, Maura Gasparetto, Philip A. Beer, Gudmundur L. Norddahl, Ping Xiang, Ling Chen, Tobias Berg, Garrett W. Rhyasen, Patricia Rosten, Gyeongsin Park, Yeonsook Moon, Andrew P. Weng, Connie J. Eaves, R. Keith Humphries

Blood (2014) 124 (24): 3608–3612.

https://doi.org/10.1182/blood-2014-04-564666

Published: 2014

Includes: Supplemental data

Journal Articles

Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study

Ian W. Flinn, Richard van der Jagt, Brad S. Kahl, Peter Wood, Tim E. Hawkins, David MacDonald, Mark Hertzberg, Yiu-Lam Kwan, David Simpson, Michael Craig, Kathryn Kolibaba, Samar Issa, Regina Clementi, Doreen M. Hallman, Mihaela Munteanu, Ling Chen, John M. Burke

Blood (2014) 123 (19): 2944–2952.

https://doi.org/10.1182/blood-2013-11-531327

Published: 2014

Includes: Supplemental data

Journal Articles

The Senescence-Associated Secretory Phenotype In Multiple Myeloma

Tanya M Wildes, MD, MSCI, Jacob Paasch, BS, Mark A. Fiala, BS, CCRP, Ling Chen, PhD, Ravi Vij, MD, Keith E. Stockerl-Goldstein, MD, Sheila Stewart, PhD, Graham A. Colditz, MD, DrPH, Michael Tomasson, MD

Blood (2013) 122 (21): 5357.

https://doi.org/10.1182/blood.V122.21.5357.5357

Published: 2013

Journal Articles

An Open-Label, Randomized Study of Bendamustine and Rituximab (BR) Compared with Rituximab, Cyclophosphamide, Vincristine, and Prednisone (R-CVP) or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in First-Line Treatment of Patients with Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL): The Bright Study

Ian W. Flinn, MD, PhD, Richard H. Van der Jagt, MD, Brad S. Kahl, M.D., Peter Wood, MRCP, Tim E. Hawkins, MBChB, David MacDonald, MD, FRCPC, Mark Hertzberg, MBBS, PhD, Yiu-Lam Kwan, MBBS, David Simpson, MBChB, Michael Craig, MD, Kathryn Kolibaba, MD, Samar Issa, MBChB, FRACP, FRCPA, Mihaela C. Munteanu, MS, Regina Clementi, RN, MS, Ling Chen, PhD, John M. Burke, MD

Blood (2012) 120 (21): 902.

https://doi.org/10.1182/blood.V120.21.902.902

Published: 2012

Journal Articles

Differences in Quality of Life Between Bendamustine Plus Rituximab Compared with Standard First-Line Treatments in Patients with Previously Untreated Advanced Indolent Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma

John M. Burke, MD, Richard H. Van der Jagt, MD, Brad S. Kahl, M.D., Peter Wood, MRCP, Tim E. Hawkins, MBChB, David MacDonald, MD, FRCPC, Mark Hertzberg, MBBS, PhD, Yiu-Lam Kwan, MBBS, David Simpson, MBChB, Michael Craig, MD, Kathryn Kolibaba, MD, Samar Issa, MBChB, FRACP, FRCPA, Richard E. White, PhD, MPH, MBE, Mihaela C. Munteanu, MS, Regina Clementi, RN, MS, Ling Chen, PhD, Ian W. Flinn, MD, PhD

Blood (2012) 120 (21): 155.

https://doi.org/10.1182/blood.V120.21.155.155

Published: 2012

Journal Articles

Aberrant Expression of Golgin-84 in Non-Hodgkin Lymphomas and Plasma Cell Myeloma

Ling Chen, Yaling Yang, PhD, C. Cameron Yin, MD, PhD, Gary Lu, MD, Su Chen, MD, PhD, Xiaoyan Huang, MD., MS, Jiayu Chen, PhD, Felix Chang, Effie Rahman, Steliana Calin, MD, L. Jeffrey Medeiros, MD, Roberto N. Miranda, MD, M. James You, MD, PhD

Blood (2011) 118 (21): 4633.

https://doi.org/10.1182/blood.V118.21.4633.4633

Published: 2011

Journal Articles

Frequent Epigenetic Inactivation of MSX2 In Acute Myeloid Leukemia

Chen Zhao, MD, PhD, Xin Han, MD, MS, Yu H. Zhang, MD, Xiaoyan Huang, MD., MS, Aili Dai, MS, Gary Lu, MD, C. Cameron Yin, MD, PhD, Ling Chen, M. James You, MD, PhD

Blood (2010) 116 (21): 4645.

https://doi.org/10.1182/blood.V116.21.4645.4645

Published: 2010

Journal Articles

Inactivation of INK4a/ARF Accelerates the Development of PTEN Deficient T-ALL

Yaling Yang, PhD, Xiuhua Gao, MD, PhD, Xin Han, MD, MS, Xiaoyan Huang, MD., MS, Qing Liu, MS, Yu H. Zhang, MD, C. Cameron Yin, MD, PhD, Ling Chen, M. James You, MD, PhD

Blood (2010) 116 (21): 4197.

https://doi.org/10.1182/blood.V116.21.4197.4197

Published: 2010

Journal Articles

Epigenetic Inactivation of DBC1 in Acute Myeloid Leukaemia.

Chen Zhao, MD, PhD, Aili Dai, Ling Chen, Xiaoping Sun, MD, PhD, Xin Han, MD, MS, C. Cameron Yin, M. James You, MD, PhD

Blood (2009) 114 (22): 4429.

https://doi.org/10.1182/blood.V114.22.4429.4429

Published: 2009

Journal Articles

Ceramide induces p38 MAPK and JNK activation through a mechanism involving a thioredoxin-interacting protein-mediated pathway

Chia-Ling Chen, Chiou-Feng Lin, Wen-Tsan Chang, Wei-Ching Huang, Chiao-Fang Teng, Yee-Shin Lin

Blood (2008) 111 (8): 4365–4374.

https://doi.org/10.1182/blood-2007-08-106336

Published: 2008

Includes: Supplemental data

Journal Articles

The hydroxyurea-induced small GTP-binding protein SAR modulates γ-globin gene expression in human erythroid cells

Delia C. Tang, Jianqiong Zhu, Wenli Liu, Kyung Chin, Jun Sun, Ling Chen, John A. Hanover, Griffin P. Rodgers

Blood (2005) 106 (9): 3256–3263.

https://doi.org/10.1182/blood-2003-10-3458

Published: 2005

Journal Articles

In Vitro Hematopoietic Lineage Interconversion from Human Bone Marrow Stem and Progenitor Cells.

Ling Chen, MD, PhD, Stephanie Jean-Noel, BA, Kevin Hall, PhD, Ying Shi, PhD, Griffin P. Rodgers, MD.

Blood (2004) 104 (11): 4160.

https://doi.org/10.1182/blood.V104.11.4160.4160

Published: 2004

Journal Articles

Adenovirus Vector-Based Purging of Multiple Myeloma Cells

Gerrard Teoh, Ling Chen, Mitsuyoshi Urashima, Yu-Tzu Tai, Leo A. Celi, Dongshu Chen, Dharminder Chauhan, Atsushi Ogata, Robert W. Finberg, Iain J. Webb, Donald W. Kufe, Kenneth C. Anderson

Blood (1998) 92 (12): 4591–4601.

https://doi.org/10.1182/blood.V92.12.4591

Published: 1998

NARROW

Assessment of Maintenance Rituximab after First-Line Bendamustine-Rituximab in Patients with Follicular Lymphoma: An Analysis from the BRIGHT Trial

Open-Label Study of Bendamustine Hydrochloride in Chinese Patients with Indolent Non-Hodgkin Lymphoma (NHL) Refractory to Rituximab Treatment

Down-Regulation of c-Kit Receptor on Hematopoietic Cells By Stem Cell Factor (SCF; c-Kit-ligand): No Impact on Transplantation

Modeling de novo leukemogenesis from human cord blood with MN1 and NUP98HOXD13

Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study

The Senescence-Associated Secretory Phenotype In Multiple Myeloma

Differences in Quality of Life Between Bendamustine Plus Rituximab Compared with Standard First-Line Treatments in Patients with Previously Untreated Advanced Indolent Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma

Aberrant Expression of Golgin-84 in Non-Hodgkin Lymphomas and Plasma Cell Myeloma

Frequent Epigenetic Inactivation of MSX2 In Acute Myeloid Leukemia

Inactivation of INK4a/ARF Accelerates the Development of PTEN Deficient T-ALL

Epigenetic Inactivation of DBC1 in Acute Myeloid Leukaemia.

Ceramide induces p38 MAPK and JNK activation through a mechanism involving a thioredoxin-interacting protein-mediated pathway

The hydroxyurea-induced small GTP-binding protein SAR modulates γ-globin gene expression in human erythroid cells

In Vitro Hematopoietic Lineage Interconversion from Human Bone Marrow Stem and Progenitor Cells.

Adenovirus Vector-Based Purging of Multiple Myeloma Cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only